https://kbio.com/resource/plant-based-antibody-manufacturing/ 2024-04-11T21:47:05+00:00 https://kbio.com/resource/chapter-twelve-manufacturing-plant-made-monoclonal-antibodies-for-research-or-therapeutic-applications/ 2024-04-11T21:50:35+00:00 https://kbio.com/resource/reversion-of-advanced-ebola-virus-disease-in-nonhuman-primates-with-zmapp/ 2024-04-11T21:57:59+00:00 https://kbio.com/resource/chimeric-plantibody-passively-protects-mice-against-aerosolized-ricin-challenge/ 2024-04-11T21:59:44+00:00 https://kbio.com/resource/efficient-in-vitro-and-in-vivo-activity-of-glyco-engineered-plant-produced-rabies-monoclonal-antibodies-e559-and-62-71-3/ 2024-04-11T22:00:48+00:00 https://kbio.com/resource/hexavalent-sperm-binding-igg-antibody-released-from-vaginal-film-for-development-of-potent-on-demand-nonhormonal-female-contraception/ 2024-04-11T22:01:55+00:00 https://kbio.com/resource/reproducibility-and-flexibility-of-monoclonal-antibody-production-with-nicotiana-benthamiana/ 2024-04-11T22:03:53+00:00 https://kbio.com/resource/italy-introducing-a-plant-based-molecular-global-farming-network/ 2024-04-11T22:04:51+00:00 https://kbio.com/resource/what-do-you-think-was-the-single-most-consequential-event-or-result-in-pharma-biopharma-in-2023/ 2024-04-11T22:05:47+00:00 https://kbio.com/resource/scrip-askswhat-does-2024-hold-for-biopharma-part-4-transformative-technology/ 2024-04-11T22:06:38+00:00 https://kbio.com/resource/what-strategies-are-being-employed-to-accelerate-product-development-and-commercialization-without-compromising-quality/ 2024-04-11T22:07:21+00:00